References
- No authors listedRandomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17 187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative GroupLancet1988286073493602899772
- Antithrombotic Trialists’ CollaborationCollaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high-risk patientsBMJ20023247329718611786451
- Antithrombotic Trialists’ (ATT) CollaborationBaigentCBlackwellLAspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trialsLancet200937396781849186019482214
- HallSLLorencTSecondary prevention of coronary artery diseaseAm Fam Physician201081328929620112887
- BartolucciAATenderaMHowardGMeta-analysis of multiple primary prevention trials of cardiovascular events using aspirinAm J Cardiol2011107121796180121481826
- RidkerPMCookNRLeeIMA Randomized Trial of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease in WomenN Engl J Med2005352131293130415753114
- HanssonLZanchettiACarruthersSGEffects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trialLancet19983519118175517629635947
- KjeldsenSEKollochRELeonettiGInfluence of gender and age on preventing cardiovascular disease by antihypertensive treatment and acetylsalicylic acid: the HOT studyJ Hypertens200018562964210826567
- de GaetanoGCollaborative Group of the Primary Prevention ProjectLow-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practiceLancet20013579250899511197445
- SaccoMPellegriniFRoncaglioniMCPrimary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trialDiabetes Care200326123264327214633812
- No authors listedFinal report on the aspirin component of the ongoing Physicians’ Health Study. Steering Committee of the Physicians’ Health Study Research GroupN Engl J Med198932131291352664509
- PetoRGrayRCollinsRRandomised trial of prophylactic daily aspirin in British male doctorsBr Med J (Clin Res Ed)19882966618313316
- No authors listedThrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. The Medical Research Council’s General Practice Research FrameworkLancet199835190982332419457092
- HuangESStrateLLHoWWLeeSSChanATLong Term Use of Aspirin and the Risk of Gastrointestinal BleedingAm J Med2011124542643321531232
- GazianoJMGreenlandPWhen Should Aspirin Be Used for Prevention of Cardiovascular Events?JAMA2014312232503250425402671
- IkedaYShimadaKTeramotoTLow-Dose Aspirin for Primary Prevention of Cardiovascular Events in Japanese Patients 60 Years or Older With Atherosclerotic Risk Factors A Randomized Clinical TrialJAMA2014312232510252025401325
- University of OxfordASCEND: A Study of Cardiovascular Events iN Diabetes Available from: https://clinicaltrials.gov/ct2/show/NCT00135226. NLM identifier: NCT00135226Accessed June 9, 2015
- BayerA Study to Assess the Efficacy and Safety of Enteric-Coated Acetylsalicylic Acid in Patients at Moderate Risk of Cardiovascular Disease (ARRIVE) Available from: https://clinicaltrials.gov/ct2/show/NCT00501059. NLM identifier: NCT00501059Accessed June 9, 2015
- Minneapolis Medical Research FoundationAspirin in Reducing Events in the Elderly (ASPREE) Available from: https://clinicaltrials.gov/ct2/show/NCT01038583. NLM identifier: NCT01038583Accessed June 9, 2015